Narrative Medicine Brings the Daily Weight of Hidradenitis Suppurativa Into View
Hidradenitis suppurativa is often discussed in terms of lesions, drainage, pain, and recurrence. This multicentre Italian qualitative project moved the conversation to a different register: how the disease is lived, narrated, and carried by patients, caregivers, and dermatologists across routine care. By using narrative medicine tools rather than standard quantitative instruments alone, the study captured the emotional strain and social disruption that often remain invisible in clinic notes and trial endpoints.
The design matters because HS rarely behaves like a simple skin condition. Its relapsing course, lesion locations, malodor, scarring, and pain can reshape work, intimacy, clothing choices, mobility, and self-image. A purely numerical assessment can miss the cumulative pressure of those changes. Narrative methods are well suited to a disorder like HS, where shame, frustration, and uncertainty often travel alongside inflammation.
Eight Italian Centers, Three Perspectives, One Shared Burden
Investigators collected in-depth narratives from three respondent groups: patients, caregivers, and dermatologists. That structure gave the project a wider lens than a conventional patient-only interview study. It also allowed the team to compare how the disease is experienced at the bedside, at home, and in the clinical encounter itself.
Eight Italian HS expert centers participated, broadening the clinical settings and patient profiles represented in the narratives. In practice, a multicentre framework helps reduce the risk that the findings reflect a single clinic culture or a narrow referral pattern. In a disease as heterogeneous as HS, the difference between a patient seen in an early, less severe phase and one with longstanding, treatment-resistant disease can be clinically and emotionally substantial.
The project used illness plots with a metaphorical framework and parallel charts. Those tools are designed to elicit fuller accounts of suffering, care relationships, and unmet needs, rather than forcing experience into pre-set survey categories. In HS, that is not a cosmetic methodological choice. It is a way to surface the hidden mechanisms of burden: social withdrawal after flares, altered self-perception after scarring, tension in family relationships, and the exhausting effort required to seek repeated care for a condition that may be dismissed or misunderstood.
Why Emotional Distress Becomes Part of the Disease Course
The emotional burden of HS is not separate from the dermatologic process. Chronic pain, visible lesions, drainage, and odor can drive avoidance behaviors, which in turn amplify isolation and distress. Recurrent flares create uncertainty, and uncertainty itself becomes a source of suffering. When patients anticipate embarrassment or rejection, they may withdraw from work, relationships, exercise, and other activities that normally buffer mental health.
Caregivers occupy a difficult middle ground. They witness the physical consequences, but they also absorb the practical and emotional consequences of an unpredictable disease. Dermatologists, for their part, may understand the inflammatory biology of HS while still underestimating the cumulative social cost of each flare. A narrative medicine framework helps align those perspectives. It can reveal when clinician priorities, patient priorities, and caregiver concerns overlap, and when they diverge.
One sentence from the study’s structure captures the clinical reality: HS was evaluated not only as an inflammatory disorder, but as an illness that reorganizes relationships.
Methodological Rigor Without Losing the Human Voice
The team did not treat narrative work as impressionistic commentary. A structured coding process was used, beginning with team-based calibration on an initial narrative sample. The coding frame was then refined iteratively, and the project followed Standards for Reporting Qualitative Research guidelines. Those steps matter because qualitative research can only inform clinical practice if it is transparent, reproducible, and disciplined enough to support interpretation.
That kind of rigor is especially important in narrative medicine. Stories are rich, but they can also be chaotic, emotionally charged, and difficult to compare across participants. A stable coding process allows the research team to identify recurring themes without flattening individual experience. In a condition like HS, that balance is essential: the disease is common enough to require generalizable insights, yet personal enough that a single pattern never tells the whole story.
The study’s strength lies in the combination of depth and breadth. Narrative tools generated clinically meaningful detail, while the multicentre Italian sample widened the range of lived experience. The inclusion of dermatologists alongside patients and caregivers also strengthened contextual validity, because the burden of HS is negotiated in both the consultation room and the home environment.
What This Means for Dermatology Practice
For clinicians, the practical implication is straightforward. HS management cannot stop at lesion counts or procedural planning. When a patient describes missed work, strained relationships, embarrassment, or withdrawal from daily life, those complaints are not ancillary. They are part of the disease phenotype as it is experienced by the person sitting in front of the clinician.
Narrative medicine does not replace physical examination, staging systems, or pharmacologic decision-making. It fills a gap those tools leave open. A patient with apparently similar skin findings may carry a vastly different psychosocial burden depending on pain, odor, lesion location, caregiving support, and prior experiences with stigma or dismissal. Listening for those differences can alter counseling, follow-up planning, and referrals for psychological or social support.
The project also reinforces a broader lesson for specialty care: expert centers should not only treat severe disease, but also document how severe disease is lived. HS is a disorder in which symptom control, dignity, and social functioning are tightly linked. Separating them too neatly risks missing the true burden.
Limits of a Qualitative Design in HS Research
Because this was a qualitative narrative medicine project, it was built to explore experience rather than measure incidence, risk reduction, or treatment effect. The findings cannot be translated into percentages, effect sizes, or comparative efficacy claims. They are meant to deepen clinical understanding, not to replace controlled outcome data.
The abstract also makes clear that the pragmatic value of the work depends on interpretation within qualitative boundaries. Narrative research can illuminate suffering and care gaps with unusual precision, but it does not answer therapeutic questions about which drug, procedure, or pathway delivers the best inflammatory control. It is strongest when used to complement quantitative studies, not to stand in for them.
What remains clinically important is narrower and more concrete: HS carries a social and emotional burden that standard dermatology metrics routinely miss. The narratives collected across eight Italian expert centers show why those dimensions belong in routine assessment, especially in a disease where stigma, pain, and recurrence can erode quality of life long before a visit note captures the full story.